Fig. 8: SARS-CoV-2 (predicted) viral load in patients. | Nature Communications

Fig. 8: SARS-CoV-2 (predicted) viral load in patients.

From: Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

Fig. 8

A SARS-CoV-2 viral load in patients. B Predicted SARS-CoV-2 viral load in patients. C Predicted SARS-CoV-2 viral load in selected patients. SARS-CoV-2 viral load (copies/mL) measured by RT-PCR from nasopharyngeal swabs of COVID-19 patients (standard of care: red; convalescent plasma: blue) at enrollment (day 1) and day 3, day 7, day 10, and day 14 after enrollment. Box plots indicate median (middle line), 25th, 75th percentile (box), and 5th and 95th percentile (whiskers), as well as outliers (single points). Predicted evolution mean (solid line) and 95% CI (shaded area) of SARS-CoV-2 log(Viral Load) in log(copies/ml) per day since enrollment (D = 1) for COVID-19 patients (standard of care: red; convalescent plasma: blue). Predicted evolution mean (solid line) and 95% CI (shaded area) of absolute log(Viral Load) in log(copies/ml) per day since enrollment (D = 1) for COVID-19 patients (standard of care: red; convalescent plasma: blue) excluding subjects who had SARS-CoV-2 viral load equal to zero at day 1 of enrollment.

Back to article page